News
Kiniksa Pharmaceuticals, Ltd. – KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 – – KPL-387 Phase 1 single ascending dose data support profile for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results